fludarabine has been researched along with Lymphocytopenia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghavamzadeh, A; Hamdi, A; Hamidieh, AA; Nabavi, M; Pourpak, Z | 1 |
| Baba, J; Ichikawa, K; Igarashi, N; Ishikawa, D; Kagamu, H; Kondo, R; Koshio, J; Koya, T; Miura, S; Nakata, K; Narita, I; Nozaki, K; Okajima, M; Saida, Y; Sato, K; Shoji, S; Tanaka, J; Tanaka, T; Watanabe, S; Yoshizawa, H | 1 |
| Burgaleta, C; Cabrera, C; Canales, M; De la Serna, J; Fernández de Sevilla, A; Gonzalez, M; Martínez, R; Martínez-López, J; Montalbán, C; Monteagudo, MD; Paz-Carreira, J; Peñalver, FJ; Peñarrubia, MJ; Prieto, E; Queizán, JA; Rapado, I; Rivero, A; Salar, A; Sánchez-Godoy, P; Tomás, JF | 1 |
| Brewer, SC; Cleveland, KO; Gelfand, MS | 1 |
| Canales, M; de la Serna, J; de Oña, R; de Sevilla, AF; Martínez, R; Martínez-López, J; Montalbán, C; Paz-Carreira, J; Rapado, I; Rivero, A; Sánchez-Godoy, P; Tomás, JF | 1 |
| Jordheim, LP | 1 |
| Ellwanger, S; Gibney, G; Janssen, W; Kudchadkar, R; Kuhn, L; Marzban, S; Mulé, JJ; Pilon-Thomas, S; Royster, E; Sarnaik, AA; Sondak, VK; Weber, J; Zager, J | 1 |
| Austin, HA; Balow, JE; Boumpas, DT; Chitkara, P; Fleisher, T; Illei, GG; Klippel, JH; Kuroiwa, T; Schlimgen, R; Tisdale, JF; Yarboro, CH | 1 |
| Cummins, M; Deane, M; Emery, V; Gor, D; Griffith, PD; Macmahon, ME; Prentice, HG | 1 |
2 trial(s) available for fludarabine and Lymphocytopenia
| Article | Year |
|---|---|
Efficacy of adoptive cell transfer of tumor-infiltrating lymphocytes after lymphopenia induction for metastatic melanoma.
Topics: Adult; Aged; Cyclophosphamide; Female; Follow-Up Studies; Humans; Immunotherapy, Adoptive; Interleukin-2; Lymphocytes, Tumor-Infiltrating; Lymphopenia; Male; Melanoma; Middle Aged; Pilot Projects; Skin Neoplasms; Treatment Outcome; Tumor Cells, Cultured; Vidarabine | 2012 |
Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis.
Topics: Adult; Aged; CD4 Lymphocyte Count; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Lymphopenia; Male; Middle Aged; Neutropenia; Pilot Projects; Proteinuria; Treatment Outcome; Vidarabine | 2007 |
7 other study(ies) available for fludarabine and Lymphocytopenia
| Article | Year |
|---|---|
Successful fludarabine-based hematopoietic stem cell transplantation in a pediatric patient with idiopathic CD4+ lymphocytopenia.
Topics: CD4-Positive T-Lymphocytes; Child; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphopenia; Myeloablative Agonists; Opportunistic Infections; Transplantation Conditioning; Treatment Outcome; Vidarabine | 2013 |
Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy.
Topics: Adoptive Transfer; Animals; Cisplatin; Cyclophosphamide; Cytotoxins; Deoxycytidine; Drug Resistance; Etoposide; Female; Fibrosarcoma; Gemcitabine; Lymph Nodes; Lymphocyte Depletion; Lymphopenia; Methylcholanthrene; Mice; Mice, Inbred C57BL; Mice, Knockout; Paclitaxel; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Tumor Cells, Cultured; Vidarabine; Whole-Body Irradiation | 2015 |
Influence of MBL-2 mutations in the infection risk of patients with follicular lymphoma treated with rituximab, fludarabine, and cyclophosphamide.
Topics: Adult; Aged; Alleles; Anti-Infective Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Cyclophosphamide; Early Termination of Clinical Trials; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Variation; Haplotypes; Humans; Infections; Lymphoma, Follicular; Lymphopenia; Male; Mannose-Binding Lectin; Middle Aged; Multicenter Studies as Topic; Neutropenia; Prospective Studies; Risk; Rituximab; Spain; Vidarabine; Young Adult | 2009 |
Rhodococcus equi pneumonia in a patient with fludarabine-treated chronic lymphocytic leukemia and CD4-lymphopenia.
Topics: Actinomycetales Infections; Aged, 80 and over; Anti-Bacterial Agents; Antineoplastic Agents; Bronchoalveolar Lavage Fluid; CD4 Lymphocyte Count; Chronic Disease; Female; Humans; Leukemia, Lymphoid; Lymphopenia; Opportunistic Infections; Pneumonia, Bacterial; Rhodococcus equi; Vidarabine | 2010 |
Relationship between deoxycytidine kinase (DCK) genotypic variants and fludarabine toxicity in patients with follicular lymphoma.
Topics: Alleles; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Deoxycytidine Kinase; DNA Mutational Analysis; Drug-Related Side Effects and Adverse Reactions; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Leukemic; Gene Frequency; Genotype; Humans; Kaplan-Meier Estimate; Logistic Models; Lymphoma, Follicular; Lymphopenia; Neutropenia; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome; Vidarabine | 2011 |
Further evidences for pharmacogenetic assessment of nucleoside analogue-treated patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine Kinase; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Leukemic; Humans; Lymphoma, Follicular; Lymphopenia; Neutropenia; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Treatment Outcome; Vidarabine | 2011 |
Quantification of CMV viraemia in a case of transfusion-related graft-versus-host disease associated with purine analogue treatment.
Topics: Acute Disease; Adult; Antineoplastic Agents; Cytomegalovirus Infections; Fatal Outcome; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Leukemia, Myeloid; Lymphopenia; T-Lymphocytes; Transfusion Reaction; Vidarabine; Viremia | 1997 |